650-血管STING激活促进小细胞肺癌NK细胞免疫治疗 episode artwork

EPISODE · Mar 16, 2026 · 14 MIN

650-血管STING激活促进小细胞肺癌NK细胞免疫治疗

from 聊聊Sci

这项研究探讨了小细胞肺癌(SCLC)通过抑制MHC-I类分子表达来逃避免疫监管的机制。虽然这类神经内分泌肿瘤理论上对自然杀伤(NK)细胞高度敏感,但临床观察发现免疫细胞被排除在肿瘤区域之外。通过创新的DynaMITE-seq技术和三维微生理模型,研究人员确认肿瘤血管系统是阻碍免疫细胞进入的关键屏障。实验证明,激活血管中的STING信号通路能上调粘附分子的表达,从而诱导NK细胞的招募与渗透。这种策略不仅能增强内源性免疫反应,还能显著提升DLL3靶向的CAR-NK细胞疗法在实体瘤中的杀伤效力。这项工作为将“冷肿瘤”转变为“热肿瘤”并优化细胞免疫治疗提供了新的临床思路。References: Campisi M, Osaki T, Dryg I, et al. Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer[J]. Cancer Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Mar 16, 2026

Embed this episode

Ready to play

650-血管STING激活促进小细胞肺癌NK细胞免疫治疗

0:00 14:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 14 minutes long.

When was this 聊聊Sci episode published?

This episode was published on March 16, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!